Physician profile
Saeed Bazzi
NPI 1902301062
$1,397.55
in general payments reported to CMS, 2019-2025
16 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71.52 · 2020: $23.72 · 2021: $135 · 2022: $245 · 2023: $505 · 2024: $298 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $923.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $922.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $586.39 | 2019-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Lilly USA, LLC | $313.51 | 2023-2025 | Mounjaro, Trulicity, Jardiance |
| Neurocrine Biosciences, INC. | $104.08 | 2022-2024 | Ingrezza |
| Abbvie INC. | $70.79 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $65.76 | 2022-2025 | Farxiga |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $63.33 | 2019-2024 | Xifaxan |
| Sanofi-Aventis U.S. LLC | $37.58 | 2020-2021 | |
| Otsuka America Pharmaceutical, INC. | $26.79 | 2022-2023 | Rexulti |
| Janssen Pharmaceuticals, INC | $23.90 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.14 | 2024 | |
| Allergan, INC. | $17.75 | 2019 | |
| Axsome Therapeutics, INC. | $14.80 | 2025 | Auvelity |
| Novo Nordisk INC | $14.71 | 2021 | |
| Amarin Pharma, INC. | $14.70 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $14.35 | 2024 | Eliquis |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $10.97 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saeed Bazzi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.